UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 11.

Schneider, P M; Vallböhmer, D; Ploenes, Y; Lurje, G; Metzger, R; Ling, F C; Brabender, J; Drebber, U; Hoelscher, A H (2011). Evaluation of quality indicators following implementation of total mesorectal excision in primarily resected rectal cancer changed future management. International Journal of Colorectal Disease, 26(7):903-909.

Drebber, U; Madeja, M; Odenthal, M; Wedemeyer, I; Mönig, S P; Brabender, J; Bollschweiler, E; Hölscher, A H; Schneider, P M; Dienes, H P; Vallböhmer, D (2011). β-catenin and Her2/neu expression in rectal cancer: association with histomorphological response to neoadjuvant therapy and prognosis. International Journal of Colorectal Disease, 26(9):1127-1134.

Brabender, J; Arbab, D; Huan, X; Vallböhmer, D; Grimminger, P; Ling, F; Neiss, S; Bollschweiler, E; Schneider, P M; Hölscher, A H; Metzger, R (2009). Death-associated protein kinase (DAPK) promoter methylation and response to neoadjuvant radiochemotherapy in esophageal cancer. Annals of Surgical Oncology, 16(5):1378-1383.

Hoffmann, A C; Brabender, J; Metzger, R; Ling, F; Warnecke-Eberz, U; Lurje, G; Hoelscher, A H; Schneider, P M; Vallböhmer, D (2009). Dihydropyrimidine dehydrogenase mRNA expression in peripheral blood of rectal cancer patients is significantly associated with residual tumor and distant metastases following resection. Journal of Surgical Oncology, 99(5):296-301.

Hoffmann, A C; Kaifi, J T; Vallböhmer, D; Yekebas, E; Grimminger, P; Leers, J M; Izbicki, J R; Hölscher, A H; Schneider, P M; Metzger, R; Brabender, J (2009). Lack of prognostic significance of serum DNA methylation of DAPK, MGMT, and GSTPI in patients with non-small cell lung cancer. Journal of Surgical Oncology, 100(5):414-417.

Ling, F C; Hoelscher, A H; Vallböhmer, D; Schmidt, D; Picker, S; Gathof, B S; Bollschweiler, E; Schneider, P M (2009). Leukocyte depletion in allogeneic blood transfusion does not change the negative influence on survival following transthoracic resection for esophageal cancer. Journal of Gastrointestinal Surgery, 13(4):581-586.

Hoffmann, A C; Vallböhmer, D; Prenzel, K; Metzger, R; Heitmann, M; Neiss, S; Ling, F; Hölscher, A H; Schneider, P M; Brabender, J (2009). Methylated DAPK and APC promoter DNA detection in peripheral blood is significantly associated with apparent residual tumor and outcome. Journal of Cancer Research and Clinical Oncology, 135(9):1231-1237.

Grimminger, P P; Stöhlmacher, J; Vallböhmer, D; Schneider, P M; Hölscher, A H; Metzger, R; Danenberg, P V; Brabender, J (2009). Prognostic significance and clinicopathological associations of COX-2 SNP in patients with nonsmall cell lung cancer. Journal of Oncology, 2009:139590.

Grimminger, P; Vallböhmer, D; Hoffmann, A; Schulte, C; Bollschweiler, E; Schneider, P M; Hölscher, A H; Metzger, R; Brabender, J (2009). Quantitative analysis of survivin RNA expression in blood as a non-invasive predictor of response to neoadjuvant radiochemotherapy in esophageal cancer. Journal of Surgical Oncology, 100(6):447-451.

Vallböhmer, D; Drebber, U; Schneider, P M; Baldus, S; Bollschweiler, E; Brabender, J; Warnecke-Eberz, U; Mönig, S; Hölscher, A H; Metzger, R (2009). Surviving expression in gastric cancer: Association with histomorphological response to neoadjuvant therapy and prognosis. Journal of Surgical Oncology, 99(7):409-413.

Grimminger, P; Ling, F C; Neiss, S; Vallböhmer, D; Lurje, G; Schneider, P M; Hölscher, A H; Metzger, R; Brabender, J (2009). The role of the homeobox genes BFT and CDX2 in the pathogenesis of non-small cell lung cancer. Anticancer Research, 29(4):1281-1286.

This list was generated on Mon Jul 24 03:06:57 2017 CEST.